Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
Link to record
Permanent link

Direct link
Sandbaumhüter, Friederike A.ORCID iD iconorcid.org/0000-0003-3391-3247
Publications (8 of 8) Show all publications
Nezhyva, M., Sandbaumhüter, F. A., Andrén, P. E. & Jansson, E. T. (2025). POMC-specific Modulation of Metabolic and Immune Pathways via Melanocortin-3 Receptor Signaling. Molecular Omics, 21(5), 456-463
Open this publication in new window or tab >>POMC-specific Modulation of Metabolic and Immune Pathways via Melanocortin-3 Receptor Signaling
2025 (English)In: Molecular Omics, E-ISSN 2515-4184, Vol. 21, no 5, p. 456-463Article in journal (Refereed) Published
Abstract [en]

This proteomic study provides a nuanced mechanistic understanding of the signaling processes upon agonist binding to the melanocortin-3 receptor (MC3R). Utilizing thermal proteome profiling (TPP) combined with LC–MS, we uncovered the distinct influences of the endogenous agonists adrenocorticotropic hormone (ACTH), α-melanocyte-stimulating hormone (α-MSH), and γ-melanocyte-stimulating hormone (γ-MSH) on protein thermal stability and pathway activation. In our 2D-TPP study, transfected HEK293 cells for expression of MC3R were exposed to the three endogenous MC3R-ligands across several concentrations followed by incubation at several temperatures, centrifugation and LC–MS analysis of the resulting supernatants. This enabled us to assess the effects of type of ligand and concentration on the thermal stability of proteins in these cells. We employed a combination of multivariate analysis, differential expression, TPP and pathway analysis to deeply characterize the impact of MC3R activation on molecular mechanisms. All three ligands affected signaling pathways related to the immune system and energy homeostasis. While α-MSH significantly modulated the IL-6 pathway via STAT3, and γ-MSH prominently activated interferon signaling, ACTH uniquely affected NADPH-related proteins. All ligands shared involvement in the cAMP-PKA-CREB and varied impacts on PI3K and ERK pathways, crucial for energy metabolism. All proteomic data are available under DOI: https://doi.org/10.6019/PXD039945.

Place, publisher, year, edition, pages
Royal Society of Chemistry, 2025
National Category
Pharmaceutical Sciences
Research subject
Biopharmaceutics
Identifiers
urn:nbn:se:uu:diva-521509 (URN)10.1039/d4mo00248b (DOI)001513163400001 ()40549863 (PubMedID)
Funder
Science for Life Laboratory, SciLifeLabCarl Tryggers foundation Magnus Bergvall FoundationÅke Wiberg Foundation
Note

De två första författarna delar förstaförfattarskapet

Available from: 2024-01-24 Created: 2024-01-24 Last updated: 2026-01-07Bibliographically approved
Wenson, L., Heldin, J., Martin, M., Erbilgin, Y., Salman, B., Sundqvist, A., . . . Söderberg, O. (2025). Precise mapping of single-stranded DNA breaks by sequence-templated erroneous DNA polymerase end-labelling. Nature Communications, 16(1), Article ID 7130.
Open this publication in new window or tab >>Precise mapping of single-stranded DNA breaks by sequence-templated erroneous DNA polymerase end-labelling
Show others...
2025 (English)In: Nature Communications, E-ISSN 2041-1723, Vol. 16, no 1, article id 7130Article in journal (Refereed) Published
Abstract [en]

The ability to analyze whether DNA contains lesions is essential in identifying mutagenic substances. Currently, the detection of single-stranded DNA breaks (SSBs) lacks precision. To address this limitation, we develop a method for sequence-templated erroneous end-labelling sequencing (STEEL-seq), which enables the mapping of SSBs. The method requires a highly error-prone DNA polymerase, so we engineer a chimeric DNA polymerase, Sloppymerase, capable of replicating DNA in the absence of one nucleotide. Following the omission of a specific nucleotide (e.g., dATP) from the reaction mixture, Sloppymerase introduces mismatches directly downstream of SSBs at positions where deoxyadenosine should occur. This mismatch pattern, coupled with the retention of sequence information flanking these sites, ensures that the identified hits are bona fide SSBs. STEEL-seq is compatible with a variety of sequencing technologies, as demonstrated using Sanger, Illumina, PacBio, and Nanopore systems. Using STEEL-seq, we determine the SSB/base pair frequency in the human genome to range between 0.7 and 3.8 x 10-6 with an enrichment in active promoter regions.

Place, publisher, year, edition, pages
Springer Nature, 2025
National Category
Molecular Biology
Identifiers
urn:nbn:se:uu:diva-565592 (URN)10.1038/s41467-025-62512-4 (DOI)001548574700015 ()40759655 (PubMedID)2-s2.0-105012487075 (Scopus ID)
Funder
Swedish Cancer Society, 22 2306 PjSwedish Research CouncilKnut and Alice Wallenberg Foundation, KAW 2020.0239Knut and Alice Wallenberg Foundation, KAW 2017.0003
Available from: 2025-09-01 Created: 2025-09-01 Last updated: 2025-10-21Bibliographically approved
Jin, Z., Hammoud, H., Bhandage, A., Korol, S. V., Trujeque-Ramos, O., Koreli, S., . . . Birnir, B. (2024). GABA-mediated inhibition of human CD4+ T cell functions is enhanced by insulin but impaired by high glucose levels. EBioMedicine, 105, Article ID 105217.
Open this publication in new window or tab >>GABA-mediated inhibition of human CD4+ T cell functions is enhanced by insulin but impaired by high glucose levels
Show others...
2024 (English)In: EBioMedicine, E-ISSN 2352-3964, Vol. 105, article id 105217Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: γ-aminobutyric acid (GABA), known as the main inhibitory neurotransmitter in the brain, exerts immunomodulatory functions by interaction with immune cells, including T cells. Metabolic programs of T cells are closely linked to their effector functions including proliferation, differentiation, and cytokine production. The physiological molecules glucose and insulin may provide environmental cues and guidance, but whether they coordinate to regulate GABA-mediated T cell immunomodulation is still being examined.

METHODS: CD4+ T cells that were isolated from blood samples from healthy individuals and from patients with type 1 diabetes (T1D) were activated in vitro. We carried out metabolic assays, multiple proximity extension assay (PEA), ELISA, qPCR, immunoblotting, immunofluorescence staining, flow cytometry analysis, MS-based proteomics, as well as electrophysiology and live-cell Ca2+ imaging.

FINDINGS: We demonstrate that GABA-mediated reduction of metabolic activity and the release of inflammatory proteins, including IFNγ and IL-10, were abolished in human CD4+ T cells from healthy individuals and patients with T1D when the glucose concentration was elevated above levels typically observed in healthy people. Insulin increased GABAA receptor-subunit ρ2 expression, enhanced the GABAA receptors-mediated currents and Ca2+ influx. GABA decreased, whereas insulin sustained, hexokinase activity and glycolysis in a glucose concentration-dependent manner.

INTERPRETATION: These findings support that metabolic factors, such as glucose and insulin, influence the GABA-mediated immunomodulation of human primary T cells effector functions.

FUNDING: The Swedish Children's Diabetes Foundation, The Swedish Diabetes Foundation, The Swedish Research Council 2018-02952, EXODIAB, The Ernfors Foundation, The Thurings Foundation and the Science for Life Laboratory.

Place, publisher, year, edition, pages
Elsevier, 2024
Keywords
Calcium signaling, Cytokine, Diabetes, GABA(A) receptors, Glycolysis, Immunometabolism
National Category
Endocrinology and Diabetes
Research subject
Endocrinology and Diabetology
Identifiers
urn:nbn:se:uu:diva-534137 (URN)10.1016/j.ebiom.2024.105217 (DOI)001262073300001 ()38943728 (PubMedID)
Funder
Swedish Child Diabetes FoundationSwedish Diabetes AssociationSwedish Research Council, 2018–02952EXODIAB - Excellence of Diabetes Research in SwedenErnfors FoundationFredrik och Ingrid Thurings StiftelseScience for Life Laboratory, SciLifeLab
Available from: 2024-07-01 Created: 2024-07-01 Last updated: 2024-08-19Bibliographically approved
Nezhyva, M., Aerts, J., Sandbaumhüter, F. A., Vallianatou, T. & Jansson, E. T. (2024). Inquiry-based Learning of Proteomics and Metabolomics. Journal of Chemical Education, 101(2), 521-529
Open this publication in new window or tab >>Inquiry-based Learning of Proteomics and Metabolomics
Show others...
2024 (English)In: Journal of Chemical Education, ISSN 0021-9584, E-ISSN 1938-1328, Vol. 101, no 2, p. 521-529Article in journal (Refereed) Published
Abstract [en]

Given the rapid development of data-driven experimental procedures within the life sciences, it is important to equip students with proper skills and knowledge on how to obtain and interpret complex data. While laboratory exercises have for a long time been well established as a teaching method for life sciences, we consider there is room for improvement in how laboratory exercises are conducted. Hence, we designed a laboratory exercise course in which students at the graduate level in the European education system (M.Sc.) are challenged to pose their own biological question and write their own laboratory protocol for a proteomic study to investigate their hypothesis. Here, students are supported in their task with lectures and seminars that take them through the required details on experimental sample preparation, analysis with LC-MS, and proteomic data evaluation of biological function and relevance. According to student interviews, the inquiry-based learning concept we used here provided a deeper understanding of the laboratory protocols they wrote, according to which they eventually performed their own experiments.

Place, publisher, year, edition, pages
American Chemical Society (ACS), 2024
Keywords
Analytical chemistry, Molecularbiology, Massspectrometry, Proteins/Peptides, Multidisciplinary, Laboratory instruction, Graduate education, Inquiry-based learning, Hands-on learning
National Category
Analytical Chemistry Educational Sciences
Identifiers
urn:nbn:se:uu:diva-524279 (URN)10.1021/acs.jchemed.3c01041 (DOI)001162283800001 ()
Available from: 2024-03-05 Created: 2024-03-05 Last updated: 2025-02-18Bibliographically approved
Sandbaumhüter, F. A., Aerts, J. T., Theurillat, R., Andrén, P. E., Thormann, W. & Jansson, E. T. (2023). Enantioselective CE–MS analysis of ketamine metabolites in urine. Electrophoresis, 44(1-2), 125-134
Open this publication in new window or tab >>Enantioselective CE–MS analysis of ketamine metabolites in urine
Show others...
2023 (English)In: Electrophoresis, ISSN 0173-0835, E-ISSN 1522-2683, Vol. 44, no 1-2, p. 125-134Article in journal (Refereed) Published
Abstract [en]

The chiral drug ketamine has long-lasting antidepressant effects with a fast onset and is also suitable to treat patients with therapy-resistant depression. The metabolite hydroxynorketamine (HNK) plays an important role in the antidepressant mechanism of action. Hydroxylation at the cyclohexanone ring occurs at positions 4, 5, and 6 and produces a total of 12 stereoisomers. Among those, the four 6HNK stereoisomers have the strongest antidepressant effects. Capillary electrophoresis with highly sulfated γ-cyclodextrin (CD) as a chiral selector in combination with mass spectrometry (MS) was used to develop a method for the enantioselective analysis of HNK stereoisomers with a special focus on the 6HNK stereoisomers. The partial filling approach was applied in order to avoid contamination of the MS with the chiral selector. Concentration of the chiral selector and the length of the separation zone were optimized. With 5% highly sulfated γ-CD in 20 mM ammonium formate with 10% formic acid and a 75% filling the four 6HNK stereoisomers could be separated with a resolution between 0.79 and 3.17. The method was applied to analyze fractionated equine urine collected after a ketamine infusion and to screen the fractions as well as unfractionated urine for the parent drug ketamine and other metabolites, including norketamine and dehydronorketamine.

Place, publisher, year, edition, pages
Wiley-VCH Verlagsgesellschaft, 2023
Keywords
capillary electrophoresis–mass spectrometry, chiral separation, hydroxynorketamine, ketamine, partial filling
National Category
Analytical Chemistry Pharmaceutical Sciences
Identifiers
urn:nbn:se:uu:diva-498086 (URN)10.1002/elps.202200175 (DOI)000895479000001 ()36398998 (PubMedID)
Funder
Swedish Foundation for Strategic Research, RIF14‐0078Swedish Foundation for Strategic Research, ICA16‐0010Science for Life Laboratory, SciLifeLabSwedish Research Council, 2018-03320Swedish Research Council, 2018-05501Swedish Research Council, 2018-03988Åke Wiberg Foundation
Available from: 2023-03-09 Created: 2023-03-09 Last updated: 2023-10-29Bibliographically approved
Sandbaumhüter, F. A., Nezhyva, M., Eriksson, O., Engberg, A., Kreuger, J., Andrén, P. E. & Jansson, E. T. (2022). Well-Plate muFASP for Proteomic Analysis of Single Pancreatic Islets. Journal of Proteome Research, 21(4), 1167-1174
Open this publication in new window or tab >>Well-Plate muFASP for Proteomic Analysis of Single Pancreatic Islets
Show others...
2022 (English)In: Journal of Proteome Research, ISSN 1535-3893, E-ISSN 1535-3907, Vol. 21, no 4, p. 1167-1174Article in journal (Refereed) Published
Abstract [en]

Filter-aided sample preparation (FASP) is widely used in bottom-upproteomics for tryptic digestion. However, the sample recovery yield of this methodis limited by the amount of the starting material. While similar to 100 ng of digested protein issufficient for thorough protein identification, proteomic information gets lost with aprotein content <10 mu g due to incomplete peptide recovery from thefilter. Wedeveloped and optimized aflexible well-plate mu FASP device and protocol that issuitable for an similar to 1 mu g protein sample. In 1 mu g of HeLa digest, we identified 1295 +/- 10proteins with mu FASP followed by analysis with liquid chromatography-massspectrometry. In contrast, only 524 +/- 5 proteins were identified with the standardFASP protocol, while 1395 +/- 4 proteins were identified in 20 mu g after standard FASPas a benchmark. Furthermore, we conducted a combined peptidomic and proteomicstudy of single pancreatic islets with well-plate mu FASP. Here, we separated neuropeptides and digested the remaining on-filterproteins for bottom-up proteomic analysis. Our results indicate inter-islet heterogeneity for the expression of proteins involved inglucose catabolism, pancreatic hormone processing, and secreted peptide hormones. We consider our method to provide a usefultool for proteomic characterization of samples where the biological material is scarce. All proteomic data are available under DOI:10.6019/PXD029039

Place, publisher, year, edition, pages
American Chemical Society (ACS)American Chemical Society (ACS), 2022
Keywords
filter-aided sample preparation, islets of Langerhans, liquid chromatography-mass spectrometry, peptidomics, proteomics
National Category
Biochemistry Molecular Biology
Identifiers
urn:nbn:se:uu:diva-474322 (URN)10.1021/acs.jproteome.2c00047 (DOI)000784194300028 ()35293755 (PubMedID)
Funder
Swedish Research Council, 201803320Swedish Research Council, 2018-05501Swedish Research Council, 2018-03988Swedish Foundation for Strategic Research, RIF14-0078Swedish Foundation for Strategic Research, ICA16-0010Science for Life Laboratory, SciLifeLabÅke Wiberg Foundation
Available from: 2022-05-18 Created: 2022-05-18 Last updated: 2025-02-20Bibliographically approved
Sandbaumhüter, F. A., Gittel, C., Larenza-Menzies, M. P., Theurillat, R., Thormann, W. & Braun, C. (2021). Stereoselective methadone disposition after administration of racemic methadone to anesthetized Shetland ponies assessed by capillary electrophoresis. Electrophoresis, 42(17-18), 1826-1831
Open this publication in new window or tab >>Stereoselective methadone disposition after administration of racemic methadone to anesthetized Shetland ponies assessed by capillary electrophoresis
Show others...
2021 (English)In: Electrophoresis, ISSN 0173-0835, E-ISSN 1522-2683, Vol. 42, no 17-18, p. 1826-1831Article in journal (Refereed) Published
Abstract [en]

The enantioselectivity of the pharmacokinetics of methadone was investigated in anesthetized Shetland ponies after a single intravenous (0.5 mg/kg methadone hydrochloride; n = 6) or constant rate infusion (0.25 mg/kg bolus followed by 0.25 mg/kg/h methadone hydrochloride; n = 3) administration of racemic methadone. Plasma concentrations of l-methadone and d-methadone and their major metabolites, l- and d-2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), respectively, were analyzed by CE with highly sulfated gamma-cyclodextrin as chiral selector and electrokinetic analyte injection from liquid/liquid extracts prepared at alkaline pH. In both trials, the d-methadone concentrations were lower than those of l-methadone and the d-EDDP levels were lower than those of L-EDDP. For the case of a single intravenous bolus injection, the plasma concentration versus time profile of methadone enantiomers was analyzed with a two-compartment pharmacokinetic model. l-methadone showed a slower elimination rate constant, a lower body clearance, and a smaller steady-state volume of distribution than d-methadone. d-methadone and d-EDDP were eliminated faster than their respective l-enantiomers. This is the first study that outlines that the disposition of racemic methadone administered to anesthetized equines is enantioselective.

Place, publisher, year, edition, pages
John Wiley & SonsWiley, 2021
Keywords
Capillary electrophoresis, EDDP, Horse, Methadone enantiomers, Pharmacokinetics
National Category
Other Veterinary Science
Identifiers
urn:nbn:se:uu:diva-469117 (URN)10.1002/elps.202100115 (DOI)000652808700001 ()33978252 (PubMedID)
Available from: 2022-03-07 Created: 2022-03-07 Last updated: 2025-02-21Bibliographically approved
Rofo, F., Sandbaumhüter, F. A., Chourlia, A., Metzendorf, N. G., Morrison, J. I., Syvänen, S., . . . Hultqvist, G. (2021). Wide-Ranging Effects on the Brain Proteome in a Transgenic Mouse Model of Alzheimer's Disease Following Treatment with a Brain-Targeting Somatostatin Peptide. ACS Chemical Neuroscience, 12(13), 2529-2541
Open this publication in new window or tab >>Wide-Ranging Effects on the Brain Proteome in a Transgenic Mouse Model of Alzheimer's Disease Following Treatment with a Brain-Targeting Somatostatin Peptide
Show others...
2021 (English)In: ACS Chemical Neuroscience, E-ISSN 1948-7193, Vol. 12, no 13, p. 2529-2541Article in journal (Refereed) Published
Abstract [en]

Alzheimer’s disease is the most common neurodegenerative disorder characterized by the pathological aggregation of amyloid-β (Aβ) peptide. A potential therapeutic intervention in Alzheimer’s disease is to enhance Aβ degradation by increasing the activity of Aβ-degrading enzymes, including neprilysin. The somatostatin (SST) peptide has been identified as an activator of neprilysin. Recently, we demonstrated the ability of a brain-penetrating SST peptide (SST-scFv8D3) to increase neprilysin activity and membrane-bound Aβ42 degradation in the hippocampus of mice overexpressing the Aβ-precursor protein with the Swedish mutation (APPswe). Using LC–MS, we further evaluated the anti-Alzheimer’s disease effects of SST-scFv8D3. Following a triple intravenous injection of SST-scFv8D3, the LC–MS analysis of the brain proteome revealed that the majority of downregulated proteins consisted of mitochondrial proteins regulating fatty acid oxidation, which are otherwise upregulated in APPswe mice compared to wild-type mice. Moreover, treatment with SST-scFv8D3 significantly increased hippocampal levels of synaptic proteins regulating cell membrane trafficking and neuronal development. Finally, hippocampal concentrations of growth-regulated α (KC/GRO) chemokine and degradation of neuropeptide-Y were elevated after SST-scFv8D3 treatment. In summary, our results demonstrate a multifaceted effect profile in regulating mitochondrial function and neurogenesis following treatment with SST-scFv8D3, further suggesting the development of Alzheimer’s disease therapies based on SST peptides.

Place, publisher, year, edition, pages
American Chemical Society (ACS), 2021
Keywords
Alzheimer's disease, amyloid-beta, proteomics, somatostatin, SST-scFv8D3, LC-MS
National Category
Neurosciences
Identifiers
urn:nbn:se:uu:diva-452435 (URN)10.1021/acschemneuro.1c00303 (DOI)000672585800023 ()34170117 (PubMedID)
Funder
Swedish Research Council, 201803320Swedish Research Council, 2019-01885Swedish Research Council, 2017-02413Swedish Research Council, 2018-05501Swedish Research Council, 2018-03988Swedish Foundation for Strategic Research, RIF14-0078Swedish Foundation for Strategic Research, ICA16-0010AlzheimerfondenKnut and Alice Wallenberg FoundationThe Swedish Brain Foundation, FO2018-0292The Swedish Brain Foundation, ALZ2019-0029Olle Engkvists stiftelseScience for Life Laboratory, SciLifeLabÅhlén-stiftelsenTorsten Söderbergs stiftelseMagnus Bergvall FoundationVinnovaÅke Wiberg Foundation
Available from: 2021-09-13 Created: 2021-09-13 Last updated: 2024-04-29Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0003-3391-3247

Search in DiVA

Show all publications